Skip to main content

Table 1 The questions asked to the patients during their initial, pregnancy test day and U/S day visits

From: Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy

1st Visit (ET day)
 AGE
 BMI
 Endometrial Thickness-
 Infertility type
  - 1ry
  -2ry
 Duration of infertility
 Menstrual pattern
  - regular
  - irregular
 Infertility factor
  -anovulation
  -endometriosis
  -male factor
  -tubal factor
  -other
 Type of cycle:
  IVF
  ICSI
  IVF/ ICSI
 Patient choice:
  - Cyclogest
  - Gestone
2nd Visit (Preg. test day)
 -Pregnancy test:
  -ve
   + ve
 -Was the type of progesterone changed?
  YES
  NO
 -Side effects:-
  Perineal irritation
  Rectal itching
  Vaginal bleeding
  Vaginal or rectal leaking or discharge
  Constipation
  Discomfort after administration
  Hematoma formation
  Other
 -Patient’s compliance:
 -Patients satisfaction: 1(least satisfaction), 2, 3, 4, 5 (most satisfaction)
3rd Visit (U/S day, 7 wks. Preg.)
 -Was the type of Progesterone changed?
  YES
  NO
 -Side effects:
  Perineal irritation
  Rectal itching
  Vaginal bleeding
  Vaginal or rectal leaking or discharge
  Constipation
  Discomfort after administration
  Hematoma formation
  Other
 -Patient’s compliance:
 -Patients satisfaction: 1(least satisfaction), 2, 3, 4, 5 (most satisfaction)
 -Pregnancy outcome:
  • Biochemical
  • Clinical